Drugs targeting cell recycling could be used to suffocate cancer cells 05 May 2022 Pancreatic cancers recycle resources to fuel their survival and growth, opening up the possibility of new treatments aimed at stopping them from doing so, scientists report. Find out more Show/Hide
New centre targets ‘undruggable’ cancers after major donation 03 Apr 2022 The centre will focus on ‘targeted protein degradation’ – one of the hottest and most promising areas in drug discovery. Scientists aim to hijack normal process of protein destruction to wipe out cancer proteins that traditional targeted drugs cannot block. Find out more Show/Hide
Monte Rosa Therapeutics lists on New York Stock Exchange 10 Sep 2021 Monte Rosa Therapeutics, a biotechnology company originally formed as a spinout from science at The Institute of Cancer Research, London, partly funded by Cancer Research UK, is now listed on the Nasdaq stock exchange in New York. Find out more Show/Hide
ICR and Cancer Research UK spinout company Monte Rosa Therapeutics raises USD96m in ‘Series B’ Financing 24 Sep 2020